期刊文献+

黑素瘤中VEGF-D,MMP-7和MMP-9的表达 被引量:1

下载PDF
导出
摘要 目的:确定黑素瘤组织中血管内皮生长因子D(VEGF-D)、基质金属蛋白酶-7(MMP-7)和MMP-9表达水平及其与肿瘤侵袭和转移的关系。方法:应用免疫组化法检测16例黑素瘤和12例黑素痣组织中VEGF-D,MMP-7和MMP-9蛋白的原位表达,并与临床肿瘤的侵袭和转移进行相关分析。结果:黑素瘤组织中VEGF-D,MMP-7和MMP-9阳性表达率(75%,62.5%和56.3%)明显高于黑素痣组织(25%,16.7%,41.7%),在有淋巴转移的黑素瘤组织中,VEGF-D,MMP-7和MMP-9的表达(91.7%,66.67%和66.67%)明显高于无淋巴转移的黑素瘤组织(25%,50%和25%),均P<0.05。结论:VEGF-D,MMP-7和MMP-9与黑素瘤的侵袭和转移有关,它们的表达水平可作为预测肿瘤转移的指标,可为临床治疗提供靶点。
作者 余忠平
出处 《中国麻风皮肤病杂志》 2012年第7期479-481,共3页 China Journal of Leprosy and Skin Diseases
  • 相关文献

参考文献8

  • 1Ueda M, Temi Y, Yamashita Y, et al. Correlation between vascular endothelial growth factor- C expression and invasion phenotype in cerdcat sarcinomas. Int J Cancer 2002;98(2) :335 - 343.
  • 2Simonetti O, Lucarini G, Brancorsini D, et al. Immunohistoche- mical expression of vascular endothelial growth factor, matrix metal- loproteinase 2, and matrix metaUoproteinase 9 in cutaneous melano- cytic lesions. Cancer 2002;95(8) :1963 - 1970.
  • 3陶娟,涂亚庭.一氧化氮在血管内皮生长因子诱导恶性黑素瘤细胞增殖机制中的研究[J].中国皮肤性病学杂志,2004,18(5):269-272. 被引量:6
  • 4Mouawad R, Spano JP, Comperat E, et al. Tmnoural expression and circulating level of VEGFR - 3 (Fit - 4) in metastatic mela- noma patients: Correlation with clinical parameters and outcome. Eur J Cancer 2009;45(8) :1407 - 1414.
  • 5Faruk T, Derya D, I-Iilal O, et al. Circulating levels of vascular en- dothelial growth factor (VEGF), matrix metalloproteinase - 3 (MMP - 3), and BCL - 2 in malignant melanoma. Med Oncol 2008; 25 (4) :431 - 436.
  • 6Ribatti D, Annese T, Longo V. Angiogenesis and Melanoma. Can- cers 2010;2(1) :114- 132.
  • 7Ghosh S, Malty P. Augmented antittmaor effects of combination ther- apy with VEGF antibody and cisplatin on murine B16F10 melanoma cells. Int Immtmopharm 2007; 7 (13) : 1598 - 1608.
  • 8Due YH, Byung JL, Jin CL, et al. Expression of VEGF, HGF, IL - 6, IL- 8, MMP - 9, Telomerase in peripheral blood of patients with head and neck squamous cell carcinoma. Clin Exp Otorbinolar- yngol 2009;2(4) : 186 - 192.

二级参考文献13

  • 1Simonetti O,Lucarini G,Brancorsini D,et al.Immunohistochemical expression of vascular endothelial growth factor,matrix metalloproteinase 2,and matrix metalloproteinase 9 in cutaneous melanocytic lesions[J].Cancer,2002,95(8):1963-1970.
  • 2Shen B,Lee D,Zioncheck T.Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway[J].J BioChem,1999,274(46):33057-33063.
  • 3Anan K,Morisaki T,Katano M,et al.Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer[J].Surgery,1996,119(3):333-339.
  • 4Hofmann UB,Westphal JR,Wass ET,et al.Matrix metalloproteinnases in human melanoma cell lines and xenografts:increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression[J].Br J Cancer,1999,81(5):774-782.
  • 5Ferrara N.Molecular and biological properties of vascular endothelial growth factor[J].J Mol Med,1999,77(7):527-543.
  • 6Ferrara N,Davis-smyth T.The biology of vascular endothelial growth factor[J].Endocrine Res,1997,18(1):4-21.
  • 7Liu B,Earl H,Baban D,et al.Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF[J].Biochem Biophy Res Commun,1995,217(3):721-727.
  • 8Massi D,Franchi A,Sardi I,et al.Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions[J].J Pathol,2001,194(2):194-200.
  • 9Harris SR,Schoeffner DJ,Yoshiji H.Tumor growth enhancing effects of vascular endothelial growth factor are associated with increased nitric oxide synthase activity and inhibition of apoptosis in human breast carcinoma xenografts[J].Cancer Lett,2002,179(1)
  • 10Salvucci O,Carsana M,Bersani H,et al.Antiapoptotic role of endogenous nitric oxide in human melanoma cells[J].Cancer Res,2001,61(1):318-326.

共引文献5

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部